News

The Manila Times42m
BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025
The highly anticipated presentation will be delivered by Francisco Silva, Vice President of Research and Development at ...
World's First HLA-G Targeted Exosome Therapy for Cancer Enters U.S. Clinical Trials
A research team led by Dr. Der-Yang Cho, Superintendent of China Medical University Hospital (Taiwan), in collaboration with ...
Pharmabiz6m
MEDSIR announces positive results from TUXEDO-3 trial of patritumab deruxtecan in patients with active brain metastases and leptomeningeal disease
MEDSIR announces positive results from TUXEDO-3 trial of patritumab deruxtecan in patients with active brain metastases and leptomeningeal disease: Chicago Monday, June 9, 2025, 1 ...
The Manila Times20m
Beacon Therapeutics Strengthens Leadership Team with the Appointment of Dr. Daniel Chung as Chief Medical Officer
Beacon Therapeutics recently announced positive six-month interim safety and efficacy results from the Phase 2 DAWN trial of ...
Beacon Therapeutics (USA), Inc.: Beacon Therapeutics Strengthens Leadership Team with the Appointment of Dr. Daniel Chung as Chief Medical Officer
Dr. Chung brings over three decades of experience spanning clinical ophthalmology, academic research and gene therapy developmentLONDON and CAMBRIDGE, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Beacon T ...